Salvazo et al. and Cermelli et al. [22,25] reported that the diagnostic value of miR34a to discriminate NAFLD patients from healthy controls was comparable to that of ALT (AUC = 0.78/ 0.75 vs. 0.83). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.